BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

853 related articles for article (PubMed ID: 21448144)

  • 21. The GerdQ questionnaire and high resolution manometry support the hypothesis that proton pump inhibitor-responsive oesophageal eosinophilia is a GERD-related phenomenon.
    Savarino EV; Tolone S; Bartolo O; de Cassan C; Caccaro R; Galeazzi F; Nicoletti L; Salvador R; Martinato M; Costantini M; Savarino V
    Aliment Pharmacol Ther; 2016 Sep; 44(5):522-30. PubMed ID: 27373195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis and treatment of eosinophilic esophagitis in clinical practice.
    Abe Y; Sasaki Y; Yagi M; Yaoita T; Nishise S; Ueno Y
    Clin J Gastroenterol; 2017 Apr; 10(2):87-102. PubMed ID: 28247277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Re-examination of the cost-effectiveness of surgical versus medical therapy in patients with gastroesophageal reflux disease: the value of long-term data collection.
    Arguedas MR; Heudebert GR; Klapow JC; Centor RM; Eloubeidi MA; Wilcox CM; Spechler SJ;
    Am J Gastroenterol; 2004 Jun; 99(6):1023-8. PubMed ID: 15180720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Proton Pump Inhibitor-responsive Esophageal Eosinophilia: An Overview of Cases from One University Hospital Center].
    Ahn B; Lee DH; Lee CM; Hwang JJ; Yoon H; Shin CM; Park YS; Kim N
    Korean J Gastroenterol; 2016 Apr; 67(4):178-82. PubMed ID: 27112243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical features distinguish eosinophilic and reflux-induced esophagitis.
    Mulder DJ; Hurlbut DJ; Noble AJ; Justinich CJ
    J Pediatr Gastroenterol Nutr; 2013 Mar; 56(3):263-70. PubMed ID: 23085895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upper GI tract findings in patients with heartburn in whom proton pump inhibitor treatment failed versus those not receiving antireflux treatment.
    Poh CH; Gasiorowska A; Navarro-Rodriguez T; Willis MR; Hargadon D; Noelck N; Mohler J; Wendel CS; Fass R
    Gastrointest Endosc; 2010 Jan; 71(1):28-34. PubMed ID: 19922918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Clinical Prediction Tool Identifies Cases of Eosinophilic Esophagitis Without Endoscopic Biopsy: A Prospective Study.
    Dellon ES; Rusin S; Gebhart JH; Covey S; Speck O; Woodward K; Higgins LL; Beitia R; Madanick RD; Levinson S; Woosley JT; Shaheen NJ
    Am J Gastroenterol; 2015 Sep; 110(9):1347-54. PubMed ID: 26303128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost Effectiveness of Routine Duodenal Biopsy Analysis for Celiac Disease During Endoscopy for Gastroesophageal Reflux.
    Yang JJ; Thanataveerat A; Green PH; Lebwohl B
    Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1437-43. PubMed ID: 25818076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of eosinophilic esophagitis in an adult population undergoing upper endoscopy: a prospective study.
    Veerappan GR; Perry JL; Duncan TJ; Baker TP; Maydonovitch C; Lake JM; Wong RK; Osgard EM
    Clin Gastroenterol Hepatol; 2009 Apr; 7(4):420-6, 426.e1-2. PubMed ID: 19162236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of fluticasone propionate/salmeterol (500/50 microg) in the treatment of COPD.
    Earnshaw SR; Wilson MR; Dalal AA; Chambers MG; Jhingran P; Stanford R; Mapel DW
    Respir Med; 2009 Jan; 103(1):12-21. PubMed ID: 19010652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of clinical features in patients with eosinophilic esophagitis living in an urban and rural environment.
    Lee YJ; Redd M; Bayman L; Frederickson N; Valestin J; Schey R
    Dis Esophagus; 2015 Jan; 28(1):19-24. PubMed ID: 24382218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subepithelial collagen deposition, profibrogenic cytokine gene expression, and changes after prolonged fluticasone propionate treatment in adult eosinophilic esophagitis: a prospective study.
    Lucendo AJ; Arias A; De Rezende LC; Yagüe-Compadre JL; Mota-Huertas T; González-Castillo S; Cuesta RA; Tenias JM; Bellón T
    J Allergy Clin Immunol; 2011 Nov; 128(5):1037-46. PubMed ID: 21880354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The natural history of eosinophilic oesophagitis in the transition from childhood to adulthood.
    Menard-Katcher P; Marks KL; Liacouras CA; Spergel JM; Yang YX; Falk GW
    Aliment Pharmacol Ther; 2013 Jan; 37(1):114-21. PubMed ID: 23121227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness analysis of high-dose omeprazole infusion before endoscopy for patients with upper-GI bleeding.
    Tsoi KK; Lau JY; Sung JJ
    Gastrointest Endosc; 2008 Jun; 67(7):1056-63. PubMed ID: 18407271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eosinophilic esophagitis in patients with typical gastroesophageal reflux disease symptoms refractory to proton pump inhibitor.
    Sá CC; Kishi HS; Silva-Werneck AL; Moraes-Filho JP; Eisig JN; Barbuti RC; Hashimoto CL; Navarro-Rodriguez T
    Clinics (Sao Paulo); 2011; 66(4):557-61. PubMed ID: 21655746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Similarities and differences among eosinophilic esophagitis, proton-pump inhibitor-responsive esophageal eosinophilia, and reflux esophagitis: comparisons of clinical, endoscopic, and histopathological findings in Japanese patients.
    Jiao D; Ishimura N; Maruyama R; Ishikawa N; Nagase M; Oshima N; Aimi M; Okimoto E; Mikami H; Izumi D; Okada M; Ishihara S; Kinoshita Y
    J Gastroenterol; 2017 Feb; 52(2):203-210. PubMed ID: 27108416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for high-grade dysplasia in gastroesophageal reflux disease: is it cost-effective?
    Soni A; Sampliner RE; Sonnenberg A
    Am J Gastroenterol; 2000 Aug; 95(8):2086-93. PubMed ID: 10950062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term cost-effectiveness of medical, endoscopic and surgical management of gastroesophageal reflux disease.
    Funk LM; Zhang JY; Drosdeck JM; Melvin WS; Walker JP; Perry KA
    Surgery; 2015 Jan; 157(1):126-36. PubMed ID: 25262216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The otolaryngologic manifestations in children with eosinophilic esophagitis.
    Otteson TD; Mantle BA; Casselbrant ML; Goyal A
    Int J Pediatr Otorhinolaryngol; 2012 Jan; 76(1):116-9. PubMed ID: 22093742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Editorial: Should patients with suspected eosinophilic esophagitis undergo a therapeutic trial of proton pump inhibition?
    Hirano I
    Am J Gastroenterol; 2013 Mar; 108(3):373-5. PubMed ID: 23459046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.